Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
about
Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
P2860
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@ast
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@en
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@nl
type
label
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@ast
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@en
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@nl
prefLabel
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@ast
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@en
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@nl
P2860
P356
P1476
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
@en
P2093
David Riseberg
P2860
P356
10.4137/CMO.S26067
P407
P577
2015-01-01T00:00:00Z